Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06441162 · ClinicalTrials.gov registry record · Phase 4
Efficacy Of Combined Nebulized Hypertonic Saline and Chest Percussion Therapy in Acute Viral Bronchiolitis
A Phase 4 study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT06441162 is a Phase 4 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 75 participants.
The verdict
NCT06441162, a Phase 4 study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
This study will examine the efficacy of combined nebulized hypertonic saline with chest percussion therapy in patients age 0 to 24 months admitted to the general inpatient pediatrics unit with acute bronchiolitis. 3% nebulized hypertonic saline treatments combined with 3 minutes of chest percussion therapy will be administered every 6 hours of patients selected for the study.
Interventions
- DRUG Nebulized 3% sodium chloride solution
- DEVICE Chest percussion cups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-07-15 |
| Est. Completion | 2025-05-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06441162
The ClinicalTrials.gov registry entry for NCT06441162 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nebulized 3% sodium chloride solution is the first listed.
NCT06441162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06441162 about?
NCT06441162 is a clinical study titled "Efficacy Of Combined Nebulized Hypertonic Saline and Chest Percussion Therapy in Acute Viral Bronchiolitis". This study will examine the efficacy of combined nebulized hypertonic saline with chest percussion therapy in patients age 0 to 24 months admitted to the general inpatient pediatrics unit with acute bronchiolitis. 3% nebulized hypertonic saline treatments combined with 3 minutes of chest percussion ...
What is the current status of trial NCT06441162?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2024-07-15. Estimated completion is 2025-05-15.
What interventions are being tested in trial NCT06441162?
The interventions under investigation include: Nebulized 3% sodium chloride solution (DRUG), Chest percussion cups (DEVICE).
Who is sponsoring clinical trial NCT06441162?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.